IP Library Granted Patent US 8,906,956
Granted Patent B2
US 8,906,956 · App. 13/912,823 · Granted Dec 9, 2014

Composition comprising (−)-Δ

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,956
App. No.
13/912,823
Granted
Dec 9, 2014
Kind
B2
Abstract

A composition comprising a tetrahydrocannabinol compound, a solvent and an acid, wherein the tetrahydrocannabinol compound may be Δ 8 tetrahydrocannabinol, (−)-Δ 9 -trans-tetrahydrocannabinol or a side chain alkyl derivative of either compound, the solvent may be an oil or C 1 -C 4 alcohol (e.g. sesame oil or ethanol), and the acid may be an organic acid or a mineral acid.

Claims (45)

1. A liquid composition comprising:

(a) (−)-Δ 9 -trans-tetrahydrocannabinol,

(b) a solvent comprising sesame oil, and

(c) an acid selected from the group consisting of acetic acid, lactic acid, oxalic acid, succinic acid, salicylic acid and tartaric acid, and

wherein after up to 4 weeks at (i) 5° C., (ii) 25° C./60% relative humidity, or (iii) 40 ° C./75% relative humidity, the composition comprises:

a′) ≦3.69% cannabinol when the acid is acetic acid;

b′) ≦0.60% cannabinol when the acid is lactic acid;

c′) ≦0.12% cannabinol when the acid is oxalic acid;

d′) ≦0.1% cannabinol when the acid is succinic acid;

e′) ≦4.5% cannabinol when the acid is salicylic acid; or

f′) ≦0.12% cannabinol when the acid is tartaric acid.

2. A liquid composition comprising:

(a) (−)-Δ 9 -trans-tetrahydrocannabinol,

(b) a solvent comprising sesame oil, and

(c) phosphoric acid, and

wherein the composition comprises ≦1.08% cannabinol after up to 16 days at (i) 25° C./60% relative humidity, or (ii) 40° C./75% relative humidity.

3. A liquid composition according to claim 1 , wherein after up to 4 weeks at (i) 5° C., (ii) 25° C./60% relative humidity, or (iii) 40° C./75% relative humidity, the composition comprises:

a′) ≦0.7% Δ 8 -tetrahydrocannabinol when the acid is acetic acid;

b′) ≦0.43% Δ 8 -tetrahydrocannabinol when the acid is lactic acid;

c′) ≦0.02% Δ 8 -tetrahydrocannabinol when the acid is oxalic acid;

d′) ≦0.28% Δ 8 -tetrahydrocannabinol when the acid is succinic acid;

e′) ≦0.59% Δ 8 -tetrahydrocannabinol when the acid is salicylic acid; or

f′) ≦0.17% Δ 8 -tetrahydrocannabinol when the acid is tartaric acid.

4. A liquid composition according to claim 3 , wherein after up to 4 weeks at (i) 5° C., (ii) 25° C./60% relative humidity, or (iii) 40°C./75% relative humidity, the composition comprises:

a′) ≦3.18% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is acetic acid;

b′) ≦0.33% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is lactic acid;

c′) ≦0.35% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is oxalic acid;

d′) ≦0.25% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is succinic acid;

e′) ≦2.97% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is salicylic acid; or

f′) ≦0.13% of any impurity having a relative retention time of from 0.56 to 0.90, when the acid is tartaric acid.

5. A liquid composition according to claim 2 , wherein the composition comprises ≦3.39% of any impurity having a relative retention time of from 0.56 to 0.90after up to 16days at (i) 25° C./60% relative humidity, or (ii) 40° C./75% relative humidity.

6. A liquid composition according to claim 1 further comprising one or more anti-oxidants, antimicrobial agents, preservatives or a combination thereof.

7. A liquid composition according to claim 2 further comprising one or more anti-oxidants, antimicrobial agents, preservatives or a combination thereof.

8. A liquid composition according to claim 1 further comprising alpha-tocopherol or butylated hydroxytoluene.

9. A liquid composition according to claim 2 further comprising alpha-tocopherol or butylated hydroxytoluene.

10. A liquid composition according to claim 1 , wherein the acid is present in an amount of from 0.01-2 wt. %.

11. A liquid composition according to claim 2 , wherein the phosphoric acid is present in an amount of from 0.01-2 wt. %.

12. A liquid composition according to claim 1 , wherein the acid is present in an amount of from 0.02-1 wt. %.

13. A liquid composition according to claim 2 , wherein the phosphoric acid is present in an amount of from 0.02-1 wt. %.

14. A liquid composition according to claim 1 , wherein the acid is present in an amount of from 0.05-0.5 wt. %.

15. A liquid composition according to claim 2 , wherein the phosphoric acid is present in an amount of from 0.05-0.5 wt. %.

16. A liquid composition according to claim 1 , wherein the (−)-Δ 9 -trans-tetrahydrocannabinol is present in an amount from 0.1-15 wt. %.

17. A liquid composition according to claim 2 , wherein the (−)-Δ 9 -trans-tetrahydrocannabinol is present in an amount from 0.1-15 wt. %.

18. A liquid composition according to claim 1 , wherein the (−)-Δ 9 -trans-tetrahydrocannabinol is present in an amount from 1-10 wt. %.

19. A liquid composition according to claim 2 , wherein the (−)-Δ 9 -trans-tetrahydrocannabinol is present in an amount from 1-10 wt. %.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2022
From: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
To: MACFARLAN SMITH LIMITED
Reel/Frame 061888/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2022
From: ROSSI, RONALD; SILVERBERG, LEE JONATHAN; HOGAN, ROBERT; SHAH, RAMESH M
To: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
Reel/Frame 059714/0757 →